Novaquest Capital Management

NovaQuest Capital Management provides a range of customized, structured finance investments to meet the needs of BioPhama companies.

Business Model:

Revenue: $6.5M

Employees: 11-50

Rankings

Detailed Novaquest Capital Management Information

Geographic Data

Novaquest Capital Management headquarters map

Address: 4208 Six Forks Road

City: Raleigh

State: NC

Zip: 27609

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$2B

Metrics

4,791,867Website Global Rank

1,795Website Monthly Traffic

Twitter Followers

Description

NovaQuest Capital Management, LLC (NovaQuest) manages product and company investments in the global healthcare industry. Its primary focus is structured finance investments in late-stage clinical and commercialized biopharmaceutical products. NovaQuest invests side-by-side with global companies in their most strategic product programs, ensuring alignment with the biopharmaceutical companies. These customized, product transactions are an alternative to standard biopharmaceutical industry deal-making and help companies maximize the value of their product portfolios. In addition, NovaQuest invests in select private equity and other company securities, with a consistent focus on late-stage clinical and commercialized products. The NovaQuest team has worked together for over 12 years, investing over $1 billion into the global healthcare industry. The team began pursuing its strategy in 2000 as an investment group within Quintiles Transnational Holdings Inc. (Quintiles). Today, NovaQuest Capital Management is an independent firm managing global investment capital. It is backed by investors whose relationships with NovaQuest date back to the group’s inception. NovaQuest is meeting the evolving needs of global healthcare companies and its investors with a consistent strategy, developed over multiple years and transactions, that draws on a customized mix of investment and return elements and securities.

Contact Phone:
+19194598620

Contact Email:

Announced Date Company Transaction Money Raised
5/2018 Clinical Ink Private Equity Round 5.3M
7/2018 Mesoblast Post-IPO Equity 50M
10/2017 Myovant Sciences Post-IPO Equity 100M
10/2020 Mileutis Corporate Round 20M
11/2022 Phathom Pharmaceuticals Post-IPO Debt 40M
9/2013 PreCision Dermatology Debt Financing 67M
12/2019 InformedDNA Venture Round -
11/2018 Roivant Sciences Private Equity Round 0
6/2011 Revance Therapeutics Series D 45M
5/2011 BioCritica Private Equity Round 25M
5/2022 TARGAN Series C 0
5/2021 Aceragen Private Equity Round 0
5/2020 Arvelle Therapeutics Series A 0
5/2021 Argenta Private Equity Round 0
4/2021 Cerevel Therapeutics Post-IPO Equity 0
6/2019 Nevakar Private Equity Round 0
6/2021 Dermavant Sciences Private Equity Round 0
7/2022 Hansa Biopharma Grant 0
7/2022 Hansa Biopharma Grant 0
5/2022 TARGAN Series C 0
6/2021 Dermavant Sciences Private Equity Round 0
5/2021 Argenta Private Equity Round 0
5/2021 Aceragen Private Equity Round 0
4/2021 Cerevel Therapeutics Post-IPO Equity 0
10/2020 Mileutis Venture Round 0
5/2020 Arvelle Therapeutics Series A 0
12/2019 InformedDNA Venture Round -
6/2019 Nevakar Private Equity Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research